Nucleic Acid Binding Polymers as Anti-Inflammatory Agents
Nucleic Acid Binding Polymers as Anti-Inflammatory Agents
批准号:
8309507
负责人:
BRUCE ALAN SULLENGER
金额:
$39.25万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-01 至 2013-08-31
关键词:
Alzheimer&aposs DiseaseAmericanAnti-Inflammatory AgentsAnti-inflammatoryApplications GrantsAttenuatedAutoantibodiesAutoimmune DiseasesAutoimmune ProcessBindingBiocompatible MaterialsCCL4 geneCell Culture TechniquesCellsChemistryClinicalComplexCytosineDNADevelopmentDiseaseDisease ProgressionDisease modelDouble-Stranded RNADrug DesignEngineeringFamilyGuanineHumanImmuneInbred NZB MiceInflammationInflammatoryInflammatory Bowel DiseasesInjuryInterferon Type IInterferonsInterleukin-6KidneyKnowledgeLeadLigandsLiverMediatingModelingMolecularMolecular ProfilingMultiple SclerosisMusNucleic Acid BindingNucleic AcidsPathogenesisPathologyPatientsPatternPattern recognition receptorPharmaceutical PreparationsPolymersProductionPropertyPsoriasisRNARheumatoid ArthritisSepsisSerumSignal TransductionStagingStimulusStructureSystemic Lupus ErythematosusTLR3 geneTLR7 geneTLR8 geneTNF geneTestingTherapeutic AgentsTissuesToll-like receptorsToxic effectTreatment Efficacybasecell injuryclinically significantcytokinedesignextracellularhuman diseaseimprovedinorganic phosphatemouse modelnon-viral gene deliverynovelnovel strategiespathogenpreventprototypereceptorreceptor bindingsensoruptake
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Nucleic acid-binding polymers as anti-inflammatory agents: reducing the danger of nuclear attack.
核酸结合聚合物作为抗炎剂:减少核攻击的危险。
DOI:
10.1586/eci.11.82
发表时间:
2012
期刊:
Expert review of clinical immunology
影响因子:
4.4
作者:
[Pisetsky,DavidS, Lee,Jaewoo, Leong,KamW, Sullenger,BruceA]
通讯作者:
Sullenger,BruceA
DOI:
10.1016/j.clim.2012.04.006
发表时间:
2012-07
期刊:
Clinical immunology (Orlando, Fla.)
影响因子:
--
作者:
[Pisetsky DS]
通讯作者:
Pisetsky DS
Direct Detection and Characterization of Thrombosis In Vivo
-
批准号:10438599
-
项目类别:
-
资助金额:$73.45万
-
财政年份:2019
-
负责人:BRUCE ALAN SULLENGER
-
依托单位:
Direct Detection and Characterization of Thrombosis In Vivo
-
批准号:10201739
-
项目类别:
-
资助金额:$73.45万
-
财政年份:2019
-
负责人:BRUCE ALAN SULLENGER
-
依托单位:
Direct Detection and Characterization of Thrombosis In Vivo
-
批准号:9980489
-
项目类别:
-
资助金额:$73.45万
-
财政年份:2019
-
负责人:BRUCE ALAN SULLENGER
-
依托单位:
RNA aptamers as cell surface receptor agonists and siRNA delivery agents
-
批准号:7847451
-
项目类别:
-
资助金额:$25.9万
-
财政年份:2009
-
负责人:BRUCE ALAN SULLENGER
-
依托单位:
RNA aptamers as cell surface receptor agonists and siRNA delivery agents
-
批准号:8333428
-
项目类别:
-
资助金额:$25.12万
-
财政年份:2009
-
负责人:BRUCE ALAN SULLENGER
-
依托单位:
RNA aptamers as cell surface receptor agonists and siRNA delivery agents
-
批准号:7737559
-
项目类别:
-
资助金额:$25.9万
-
财政年份:2009
-
负责人:BRUCE ALAN SULLENGER
-
依托单位:
RNA aptamers as cell surface receptor agonists and siRNA delivery agents
-
批准号:8326373
-
项目类别:
-
资助金额:$25.12万
-
财政年份:2009
-
负责人:BRUCE ALAN SULLENGER
-
依托单位:
Ribozyme-Mediated Repair of Sickle Beta-Globin RNA and DNA
-
批准号:7407405
-
项目类别:
-
资助金额:$29.6万
-
财政年份:2007
-
负责人:BRUCE ALAN SULLENGER
-
依托单位:
E2F, INTIMAL HYPERPLASIA
-
批准号:6954604
-
项目类别:
-
资助金额:$25.14万
-
财政年份:2005
-
负责人:BRUCE ALAN SULLENGER
-
依托单位:
E2F-mediated Control of Vascular Growth and Remodeling
-
批准号:6856580
-
项目类别:
-
资助金额:$44.01万
-
财政年份:2003
-
负责人:BRUCE ALAN SULLENGER
-
依托单位:
E2F-mediated Control of Vascular Growth and Remodeling
-
批准号:6619902
-
项目类别:
-
资助金额:$41.65万
-
财政年份:2003
-
负责人:BRUCE ALAN SULLENGER
-
依托单位:
E2F-mediated Control of Vascular Growth and Remodeling
-
批准号:7028898
-
项目类别:
-
资助金额:$44.07万
-
财政年份:2003
-
负责人:BRUCE ALAN SULLENGER
-
依托单位:
E2F-mediated Control of Vascular Growth and Remodeling
-
批准号:6727700
-
项目类别:
-
资助金额:$42.9万
-
财政年份:2003
-
负责人:BRUCE ALAN SULLENGER
-
依托单位:
DISRUPTING VIRAL GENES WITH GROUP II INTRONS
-
批准号:6313209
-
项目类别:
-
资助金额:$34.27万
-
财政年份:2001
-
负责人:BRUCE ALAN SULLENGER
-
依托单位:
DISRUPTING VIRAL GENES WITH GROUP II INTRONS
-
批准号:6498880
-
项目类别:
-
资助金额:$33.79万
-
财政年份:2001
-
负责人:BRUCE ALAN SULLENGER
-
依托单位:
DISRUPTING VIRAL GENES WITH GROUP II INTRONS
-
批准号:6699051
-
项目类别:
-
资助金额:$35.6万
-
财政年份:2001
-
负责人:BRUCE ALAN SULLENGER
-
依托单位:
DISRUPTING VIRAL GENES WITH GROUP II INTRONS
-
批准号:6628953
-
项目类别:
-
资助金额:$34.68万
-
财政年份:2001
-
负责人:BRUCE ALAN SULLENGER
-
依托单位:
Antithrombotic Aptamers and Antidotes
-
批准号:8255561
-
项目类别:
-
资助金额:$51.46万
-
财政年份:2000
-
负责人:BRUCE ALAN SULLENGER
-
依托单位:
Antithrombotic Aptamers and Antidotes
-
批准号:8887727
-
项目类别:
-
资助金额:$48.15万
-
财政年份:2000
-
负责人:BRUCE ALAN SULLENGER
-
依托单位:
Antithrombotic Aptamers and Antidotes
-
批准号:9249609
-
项目类别:
-
资助金额:$46.68万
-
财政年份:2000
-
负责人:BRUCE ALAN SULLENGER
-
依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
-
批准号:81000622
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:梁胜
-
依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
-
批准号:31060293
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:郭亚芬
-
依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
-
批准号:30960334
-
项目类别:地区科学基金项目
-
资助金额:22.0万元
-
批准年份:2009
-
负责人:董贵成
-
依托单位: